Alterity Therapeutics Ltd.ASX: ATH

First Patient dosed in ATH434 Phase 2 Clinical Trial

Jul 6, 2022 at 4:11 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment